Cargando…
Auditing the safety and efficacy of interventional septal reduction therapies in hypertrophic obstructive cardiomyopathy at a specialized tertiary centre
FUNDING ACKNOWLEDGEMENTS: Type of funding sources: None. BACKGROUND: Hypertrophic cardiomyopathy (HCM) is a recognized cause of sudden cardiac death and dysrhythmias. Patients with HCM and marked left ventricular outflow tract obstruction (LVOTO) may benefit from invasive therapies such as septal my...
Autores principales: | Sorbini, M, Savvatis, K, Guttmann, O, Omahony, C, Shipolini, A, Yates, M, Rathwell, C |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10207059/ http://dx.doi.org/10.1093/europace/euad122.515 |
Ejemplares similares
-
Surpassing the complex substrate of accessory pathways ablation in ebstein anomaly
por: Laranjo, S, et al.
Publicado: (2023) -
Tachyarrhythmias after extracardiac conduit Fontan procedure in the long-term follow-up: may native anatomy of single ventricle predict their occurrence?
por: Tamborrino, P P, et al.
Publicado: (2023) -
Ventricular tachycardia substrates in young patients with repaired tetralogy of fallot
por: Wallet, J, et al.
Publicado: (2023) -
Large Atrial Septal Aneurysm Associated with Secundum Atrial Septal Defect
por: Isakadze, Nino, et al.
Publicado: (2022) -
Limitations of Percutaneous Closure of a Complex Secundum Atrial Septal Defect
por: Binder, M. Scott, et al.
Publicado: (2022)